Back to Search
Start Over
Using cerebrospinal fluid amyloid‐beta (1‐42) in the memory clinic: Concordance with PET and use of biomarker ratios across immunoassays
- Source :
- Alzheimer's & Dementia. 16
- Publication Year :
- 2020
- Publisher :
- Wiley, 2020.
- Subjects :
- Oncology
medicine.medical_specialty
biology
Epidemiology
business.industry
Amyloid beta
Health Policy
Concordance
Memory clinic
Method development
Psychiatry and Mental health
Cellular and Molecular Neuroscience
Cerebrospinal fluid
Developmental Neuroscience
Neuroimaging
Internal medicine
biology.protein
Medicine
Biomarker (medicine)
Neurology (clinical)
Geriatrics and Gerontology
business
Subjects
Details
- ISSN :
- 15525279 and 15525260
- Volume :
- 16
- Database :
- OpenAIRE
- Journal :
- Alzheimer's & Dementia
- Accession number :
- edsair.doi...........b869d6dc564ab39622687e036d7f224a
- Full Text :
- https://doi.org/10.1002/alz.045128